WZ - zwołanie walnego - komunikat spółki KRKA, TOVARNA ZDRAVIL D.D. (krka) - komunikat ESPI

Komunikat spółki

COMMON REPORT

	POLISH FINANCIAL SUPERVISION AUTHORITY
				UNI - EN REPORT No		25	/	2025
	Date of issue:		2025-05-15
	Short name of the issuer
	KRKA
	Subject
	31st Annual General Meeting notice
	Official market - legal basis
	art. 17. 1 MAR.
	Unofficial market - legal basis
	Contents of the report:
	Pursuant to the provisions of the Rules of the Ljubljana Stock Exchange, d.d., Ljubljana, Article 152 of the Market in Financial Instruments Act and Article 296 of the Companies Act, the Management Board convenes the 31st Annual General Meeting of Shareholders of Krka, d. d., Novo mesto. The convening of the 31st General Meeting and other materials are in the attached documents. The notice will be published on the Company's website (www.krka.biz) from 15 May 2025 onwards, for a minimum period of 5 years.
	Annexes
	File				Description
	31 AGM Notice.pdf				31 AGM Notice
	Explanation of proposed resolutions.pdf				Explanation of proposed resolutions
	Report on remuneration of management and supervisory board members 2024.pdf				Report on remuneration of management and supervisory board members 2024
	Shareholders rights.pdf				Shareholders rights
	Registration form.pdf				Registration form
	Proxy statement.pdf				Proxy statement

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification of the WSE in Warsow)

8501

Nove Mesto

(post code)

(city)

Smarjeska

6

(street)

(number)

+386 7 331 21 11

+386 7 332 15 37

(phone number)

(fax)

(e-mail)

(web site)

nie dotyczy

(NIP)

(REGON)

	SIGNATURE OF PERSONS REPRESENTING THE COMPANY
	Date	Name	Position / Function	Signature
	2025-05-15	Jože Colarič	President of the Management Board and CEO

Nazwa jednostki:	KRKA, TOVARNA ZDRAVIL D.D.
Nazwa skrócona jednoskti:	KRKA
Adres:	Smarjeska 6, 8501 Nove Mesto
Telefon:	+386 7 331 21 11
Fax:	+386 7 332 15 37
NIP:	nie dotyczy